BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37898441)

  • 1. Dietary γ-mangostin triggers immunogenic cell death and activates cGAS signaling in acute myeloid leukemia.
    Long ZJ; Wang JD; Qiu SX; Zhang Y; Wu SJ; Lei XX; Huang ZW; Chen JJ; Yang YL; Zhang XZ; Liu Q
    Pharmacol Res; 2023 Nov; 197():106973. PubMed ID: 37898441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction of a prognostic model of acute myeloid leukemia associated with immunogenic cell death.
    Sheng X; Lu J; Wang J; Fan K; Huang M; Lu Q
    Expert Rev Hematol; 2023; 16(7):543-551. PubMed ID: 37114857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural Compounds of Marine Origin as Inducers of Immunogenic Cell Death (ICD): Potential Role for Cancer Interception and Therapy.
    Sansone C; Bruno A; Piscitelli C; Baci D; Fontana A; Brunet C; Noonan DM; Albini A
    Cells; 2021 Jan; 10(2):. PubMed ID: 33504012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Tumor and Immune Enhancing Activities of Rice Bran Gramisterol on Acute Myelogenous Leukemia.
    Somintara S; Leardkamolkarn V; Suttiarporn P; Mahatheeranont S
    PLoS One; 2016; 11(1):e0146869. PubMed ID: 26752299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Screening of Antineoplastic Drugs for Acute Myeloid Leukemia Reveals Contrasting Immunogenic Effects of Etoposide and Fludarabine.
    Ocadlikova D; Iannarone C; Redavid AR; Cavo M; Curti A
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32948017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanomicelle protects the immune activation effects of Paclitaxel and sensitizes tumors to anti-PD-1 Immunotherapy.
    Yang Q; Shi G; Chen X; Lin Y; Cheng L; Jiang Q; Yan X; Jiang M; Li Y; Zhang H; Wang H; Wang Y; Wang Q; Zhang Y; Liu Y; Su X; Dai L; Tang M; Li J; Zhang L; Qian Z; Yu D; Deng H
    Theranostics; 2020; 10(18):8382-8399. PubMed ID: 32724476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Yes-Associated Protein 1 Inhibition Induces Immunogenic Cell Death and Synergizes With Radiation and PD-1 Blockade.
    Zhuang Y; Wang Y; Liu C; Li S; Du S; Li G
    Int J Radiat Oncol Biol Phys; 2023 Jul; 116(4):894-905. PubMed ID: 36608830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Venetoclax Synergistically Enhances the Anti-leukemic Activity of Vosaroxin Against Acute Myeloid Leukemia Cells Ex Vivo.
    Liu F; Knight T; Su Y; Edwards H; Wang G; Wang Y; Taub JW; Lin H; Sun L; Ge Y
    Target Oncol; 2019 Jun; 14(3):351-364. PubMed ID: 31115744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor Immunogenic Cell Death as a Mediator of Intratumor CD8 T-Cell Recruitment.
    Roussot N; Ghiringhelli F; Rébé C
    Cells; 2022 Nov; 11(22):. PubMed ID: 36429101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD47 agonist peptide PKHB1 induces immunogenic cell death in T-cell acute lymphoblastic leukemia cells.
    Uscanga-Palomeque AC; Calvillo-Rodríguez KM; Gómez-Morales L; Lardé E; Denèfle T; Caballero-Hernández D; Merle-Béral H; Susin SA; Karoyan P; Martínez-Torres AC; Rodríguez-Padilla C
    Cancer Sci; 2019 Jan; 110(1):256-268. PubMed ID: 30460757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cooperative effect of chidamide and chemotherapeutic drugs induce apoptosis by DNA damage accumulation and repair defects in acute myeloid leukemia stem and progenitor cells.
    Li Y; Wang Y; Zhou Y; Li J; Chen K; Zhang L; Deng M; Deng S; Li P; Xu B
    Clin Epigenetics; 2017; 9():83. PubMed ID: 28814980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of tumor intrinsic BANF1 activates antitumor immune responses via cGAS-STING and enhances the efficacy of PD-1 blockade.
    Wang M; Huang Y; Chen M; Wang W; Wu F; Zhong T; Chen X; Wang F; Li Y; Yu J; Wu M; Chen D
    J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37620043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromomycin A
    Florêncio KGD; Edson EA; Fernandes KSDS; Luiz JPM; Pinto FDCL; Pessoa ODL; Cunha FQ; Machado-Neto JA; Wilke DV
    Front Immunol; 2022; 13():941757. PubMed ID: 36439184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting purinergic pathway to enhance radiotherapy-induced immunogenic cancer cell death.
    Bao X; Xie L
    J Exp Clin Cancer Res; 2022 Jul; 41(1):222. PubMed ID: 35836249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conventional amphotericin B elicits markers of immunogenic cell death on leukemic blasts, mediates immunostimulatory effects on phagocytic cells, and synergizes with PD-L1 blockade.
    Kofla G; Radecke C; Frentsch M; Walther W; Stintzing S; Riess H; Bullinger L; Na IK
    Oncoimmunology; 2022; 11(1):2068109. PubMed ID: 35496500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenic cell death in cancer therapy: Present and emerging inducers.
    Zhou J; Wang G; Chen Y; Wang H; Hua Y; Cai Z
    J Cell Mol Med; 2019 Aug; 23(8):4854-4865. PubMed ID: 31210425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Canthin-6-one induces cell death, cell cycle arrest and differentiation in human myeloid leukemia cells.
    Vieira Torquato HF; Ribeiro-Filho AC; Buri MV; Araújo Júnior RT; Pimenta R; de Oliveira JS; Filho VC; Macho A; Paredes-Gamero EJ; de Oliveira Martins DT
    Biochim Biophys Acta Gen Subj; 2017 Apr; 1861(4):958-967. PubMed ID: 28161479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperbaric oxygen facilitates teniposide-induced cGAS-STING activation to enhance the antitumor efficacy of PD-1 antibody in HCC.
    Li K; Gong Y; Qiu D; Tang H; Zhang J; Yuan Z; Huang Y; Qin Y; Ye L; Yang Y
    J Immunother Cancer; 2022 Aug; 10(8):. PubMed ID: 36002188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blocking migration of regulatory T cells to leukemic hematopoietic microenvironment delays disease progression in mouse leukemia model.
    Wang R; Feng W; Wang H; Wang L; Yang X; Yang F; Zhang Y; Liu X; Zhang D; Ren Q; Feng X; Zheng G
    Cancer Lett; 2020 Jan; 469():151-161. PubMed ID: 31669202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting transcription factor TCF4 by γ-Mangostin, a natural xanthone.
    Krishnamachary B; Subramaniam D; Dandawate P; Ponnurangam S; Srinivasan P; Ramamoorthy P; Umar S; Thomas SM; Dhar A; Septer S; Weir SJ; Attard T; Anant S
    Oncotarget; 2019 Sep; 10(54):5576-5591. PubMed ID: 31608135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.